BTG2014 HOME
DEAR COLLEAGUES,
We sincerely thank you for your participation and making the BTG2014 Taipei a grand success!! This conference truly provided a common platform for outstanding educational endeavor, high level of interaction, exchange of ideas and exposure to novel therapeutics.
BTG2014 is one of the largest and most important conferences to be held in the APAC region concerned with the research and treatment of hematologic malignancies. More than 500 hematologic malignancy experts are expected to attend this conference.
The best abstract winner, Dr Cheng-Hong Tsai from National University Taiwan, gave presentation on 'Higher expression of suppressor of cytokine signaling1 (SOCS1) in the bone marrow is an unfavorable prognostic factor in adult patients with de novo acute myeloid leukemia.'. He also won 1000 USD cash award.
We look forward to another exciting meeting next year and wish success for all!
Sincerely,
We sincerely thank you for your participation and making the BTG2014 Taipei a grand success!! This conference truly provided a common platform for outstanding educational endeavor, high level of interaction, exchange of ideas and exposure to novel therapeutics.
BTG2014 is one of the largest and most important conferences to be held in the APAC region concerned with the research and treatment of hematologic malignancies. More than 500 hematologic malignancy experts are expected to attend this conference.
The best abstract winner, Dr Cheng-Hong Tsai from National University Taiwan, gave presentation on 'Higher expression of suppressor of cytokine signaling1 (SOCS1) in the bone marrow is an unfavorable prognostic factor in adult patients with de novo acute myeloid leukemia.'. He also won 1000 USD cash award.
We look forward to another exciting meeting next year and wish success for all!
Sincerely,
 HF Tien, MD, PhD |
 Richard Champlin, MD |
 Morton Coleman, MD |
Executive Chairman & APHCON President
Xiao Jun Huang, MD, PhD